These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25652695)

  • 21. Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.
    Zhang XH; Zhang R; Li Y
    Leuk Res; 2010 Jul; 34(7):958-61. PubMed ID: 20116851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A pharmacokinetic study of the value of oral cytarabine ocfosfate in the treatment of hematological malignancies].
    Ueda Y; Mori S; Ito T; Maesako Y; Konishi H; Yagiri Y
    Rinsho Ketsueki; 1998 May; 39(5):348-54. PubMed ID: 9637884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience.
    Razzouk BI; Raimondi SC; Srivastava DK; Pritchard M; Behm FG; Tong X; Sandlund JT; Rubnitz JE; Pui CH; Ribeiro RC
    Leukemia; 2001 Sep; 15(9):1326-30. PubMed ID: 11516092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
    Mangaru Z; Shetty S; Visconte V; Liu HD; Rogers HJ
    Am J Hematol; 2016 Jun; 91(4):E273-4. PubMed ID: 26719044
    [No Abstract]   [Full Text] [Related]  

  • 25. Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).
    Creutzig U; Zimmermann M; Bourquin JP; Dworzak MN; von Neuhoff C; Sander A; Schrauder A; Teigler-Schlegel A; Stary J; Corbacioglu S; Reinhardt D
    Blood; 2011 Nov; 118(20):5409-15. PubMed ID: 21948298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
    Seftel MD; Bruyere H; Copland M; Hogge DE; Horsman DE; Nantel SH; Shepherd JD; Lavoie JC; Le A; Sutherland HJ; Toze CL; Nevill TJ
    Eur J Haematol; 2002 Oct; 69(4):193-9. PubMed ID: 12431237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia with translocation (8;21) or inversion (16) in elderly patients treated with conventional chemotherapy: a collaborative study of the French CBF-AML intergroup.
    Prébet T; Boissel N; Reutenauer S; Thomas X; Delaunay J; Cahn JY; Pigneux A; Quesnel B; Witz F; Thépot S; Ugo V; Terre C; Recher C; Tavernier E; Hunault M; Esterni B; Castaigne S; Guilhot F; Dombret H; Vey N; ; ;
    J Clin Oncol; 2009 Oct; 27(28):4747-53. PubMed ID: 19720919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.
    Tirado CA; Valdez F; Klesse L; Karandikar NJ; Uddin N; Arbini A; Fustino N; Collins R; Patel S; Smart RL; Garcia R; Doolittle J; Chen W
    Cancer Genet Cytogenet; 2010 Jul; 200(1):54-9. PubMed ID: 20513535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
    Byrd JC; Ruppert AS; Mrózek K; Carroll AJ; Edwards CG; Arthur DC; Pettenati MJ; Stamberg J; Koduru PR; Moore JO; Mayer RJ; Davey FR; Larson RA; Bloomfield CD
    J Clin Oncol; 2004 Mar; 22(6):1087-94. PubMed ID: 15020610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.
    Eghtedar A; Borthakur G; Ravandi F; Jabbour E; Cortes J; Pierce S; Kantarjian H; Garcia-Manero G
    Am J Hematol; 2012 Mar; 87(3):317-8. PubMed ID: 22228403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful treatment of refractory anemia with excess of blasts in transformation with cytarabine ocfosfate].
    Takeuchi M; Kojima K; Takaba S; Isokawa M; Tanimizu M; Kimura F; Ohmoto E; Harada M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):141-4. PubMed ID: 7826071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of cytarabine ocfosfate on colony-stimulating factor in myelodysplastic syndrome with monosomy 7].
    Masumoto A; Ohbayashi Y; Kawada H; Arimori K; Sasao T; Ogawa Y; Fujiwara H; Fukuda R; Watanabe S; Umeda Y
    Rinsho Ketsueki; 1994 Jun; 35(6):603-8. PubMed ID: 7521405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypoplastic leukemia successfully treated by oral administration with cytarabine ocfosfate].
    Okuyama Y; Kitazume K; Iwabe K; Usuki K; Urabe A
    Rinsho Ketsueki; 1994 Jun; 35(6):593-7. PubMed ID: 8078195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bundles of Auer rods in mature neutrophils in a pediatric acute myeloid leukemia patient with inv(16)(p13.1q22).
    Kim KJ; Kim IS
    Int J Lab Hematol; 2020 Aug; 42(4):e164-e166. PubMed ID: 32338823
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complete remission by cytarabine ocfosfate plus G-CSF therapy in a patient with hypoplastic RAEB-T].
    Kadowaki I; Sasaki O; Sasaki T; Ishizawa K; Kimura J; Nomura J; Furuyama K; Harigae H; Shishido T; Okuda M
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):145-7. PubMed ID: 7529978
    [No Abstract]   [Full Text] [Related]  

  • 38. High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia--is more better or more of the same?
    Wolach O; Itchaki G; Bar-Natan M; Yeshurun M; Ram R; Herscovici C; Shpilberg O; Douer D; Tallman MS; Raanani P
    Hematol Oncol; 2016 Mar; 34(1):28-35. PubMed ID: 25689584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications.
    Panigrahi C; Tikare N; Das PK; Padhi S
    BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.
    Seymour JF; Juneja SK; Campbell LJ; Ellims PH; Estey EH; Prince HM
    Leukemia; 1999 Nov; 13(11):1735-40. PubMed ID: 10557046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.